BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Cheng XW, Leng WH, Mu CL. Efficacy and safety of S-1 maintenance therapy in advanced non-small-cell lung cancer patients. World J Clin Cases 2020; 8(21): 5172-5179 [PMID: 33269253 DOI: 10.12998/wjcc.v8.i21.5172]
URL: https://www.wjgnet.com/2307-8960/full/v8/i21/5172.htm
Number Citing Articles
1
Haonan Xu, Yuwen Liang, Wenqiang Tang, Xiongxin Yang, Xiaobo Du. Efficacy and safety of anlotinib combined with S‑1 as a third‑ or later‑line treatment for advanced non‑small cell lung cancer in China: A systematic review and meta‑analysisOncology Letters 2024; 28(6) doi: 10.3892/ol.2024.14746